Verastem, Inc. (VSTM): Price and Financial Metrics


Verastem, Inc. (VSTM)

Today's Latest Price: $1.88 USD

0.05 (2.73%)

Updated Jun 5 5:27pm

Add VSTM to Watchlist
Sign Up

Overall POWR Rating


POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank


Industry Rank:

Ranked of 336 in Biotech

See all "A" rated Strong Buy stocks

VSTM Stock Summary

  • VSTM's price/sales ratio is 14.27; that's higher than the P/S ratio of 91.13% of US stocks.
  • With a year-over-year growth in debt of -54.41%, Verastem Inc's debt growth rate surpasses just 4.65% of about US stocks.
  • As for revenue growth, note that VSTM's revenue has grown -26.59% over the past 12 months; that beats the revenue growth of merely 7.27% of US companies in our set.
  • Stocks that are quantitatively similar to VSTM, based on their financial statements, market capitalization, and price volatility, are AMKR, TELL, IBIO, VJET, and NAV.
  • VSTM's SEC filings can be seen here. And to visit Verastem Inc's official web site, go to www.verastem.com.
VSTM Daily Price Range
VSTM 52-Week Price Range

VSTM Stock Price Chart More Charts


VSTM Price/Volume Stats

Current price $1.88 52-week high $4.67
Prev. close $1.83 52-week low $0.83
Day low $1.80 Volume 6,785,039
Day high $1.91 Avg. volume 4,970,987
50-day MA $2.37 Dividend yield N/A
200-day MA $1.76 Market Cap 305.56M

Verastem, Inc. (VSTM) Company Bio


Verastem, Inc. focuses on discovering and developing drugs for the treatment of cancer. Its programs target the focal adhesion kinase (FAK) and the phosphoinositide 3-kinase (PI3K)/mTOR signaling pathways. The company was founded in 2010 and is based in Needham, Massachusetts.


VSTM Latest News Stream


Event/TimeNews Detail
Loading, please wait...

VSTM Latest Social Stream


Loading social stream, please wait...

View Full VSTM Social Stream

Latest VSTM News From Around the Web

Below are the latest news stories about Verastem Inc that investors may wish to consider to help them evaluate VSTM as an investment opportunity.

Verastem Oncology to Present at the Jefferies Virtual Healthcare Conference

Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer, today announced that the Company will present at the Jefferies Virtual Healthcare Conference on Thursday, June 4, 2020 at 2:30 p.m. EDT.

Yahoo | May 28, 2020

Billionaire Steven Cohen Bets Big on These 3 Stocks

And they’re off to the races. All three of the major U.S. stock indexes popped on Monday after biotech company Moderna reported its experimental COVID-19 vaccine produced encouraging results in its Phase 1 trial, with it appearing to be safe and able to generate an immune response against the virus.While the news has inspired optimism among market watchers, one investing guru is saying slow your roll. Billionaire Steve Cohen told the employees of his investment firm, Point72 Asset Management, to use caution amid the market’s slight rebounds from low points.In a note to his staff, Cohen wrote, “Markets don’t come back in a straight line; after an earthquake there are tremors. We need to continue to be disciplined. We are seeing plenty of opportunities to generate returns, but I don’t wan...

Yahoo | May 19, 2020

Are Options Traders Betting on a Big Move in Verastem (VSTM) Stock?

Investors need to pay close attention to Verastem (VSTM) stock based on the movements in the options market lately.

Zacks Investment Research | May 18, 2020

3 Biotech Stocks Under $4 That Could Surge Over 50%

It has been almost three months since the coronavirus-driven volatility hit the global economy, and the market continues to rapidly move into both the green and the red. Yet, since its March 16 low, the S&P 500 has come a long way, rising nearly 18%. Wall Street pros remind investors that one area of the market has performed significantly better than the S&P 500: the biotech sector. As a result, names inhabiting this space have found themselves under the Street’s microscope.Having said that, there is something to consider when making these investment decisions. Biotech stocks are especially volatile due to the characteristics of the industry itself. For these companies, there are only a few key indicators like study results or regulatory approvals to determine whether or not sustainable...

Yahoo | May 14, 2020

Verastem Oncology Reports First Quarter 2020 Financial Results and Highlights Recent Company Progress

Verastem, Inc. (Nasdaq:VSTM) (also known as Verastem Oncology), a biopharmaceutical company committed to developing and commercializing new medicines for patients battling cancer, today reported financial results for the three months ending March 31, 2020, and provided an overview of recent corporate highlights.

Yahoo | May 7, 2020

Read More 'VSTM' Stories Here

VSTM Price Returns

1-mo 1.62%
3-mo -44.38%
6-mo 42.42%
1-year 49.21%
3-year -13.36%
5-year -78.37%
YTD 40.30%
2019 -60.12%
2018 9.45%
2017 174.11%
2016 -39.78%
2015 -79.65%

Continue Researching VSTM

Here are a few links from around the web to help you further your research on Verastem Inc's stock as an investment opportunity:

Verastem Inc (VSTM) Stock Price | Nasdaq
Verastem Inc (VSTM) Stock Quote, History and News - Yahoo Finance
Verastem Inc (VSTM) Stock Price and Basic Information | MarketWatch


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!



Page generated in 0.9508 seconds.